TGF‐β was shown to regulate the proliferation of RCC cells—such as those of the Caki‐2 and 786‐O cell lines—through modifying the expression of oncogenic regulators, including ETS1 [37]. The gene discussed is ETS1; the disease is renal cell carcinoma.